Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
17.35 EUR | -9.16% | -4.74% | +70.99% |
May. 15 | TD Cowen Starts NewAmsterdam Pharma With Buy Rating | MT |
May. 09 | Earnings Flash (NAMS) NEWAMSTERDAM PHARMA N.V. Reports Q1 Revenue $1.4M | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Equities
- NAMS Stock
- Revisions Frazier Lifesciences Acquisition Corporation